Today, DDMAC issued a warning letter to J&J for a webcast.
With DDMAC's new focus on digital initiatives and the influx of corresponding warning (and untitled) letters, it seems DDMAC is sending a message:
- It's not just Web sites anymore ... FDA is paying attention to all kinds of online marketing.
- The same rules apply online as they do offline. (Yeah, we know .... Boooo!)
While I'm a proponent of social media and understanding how it's shifted control to consumers, I am also a realist, and I realize there are limits.
DDMAC, it seems, is making sure those limits are well-known.